Chris Hughes
Bloomberg

Vaccine Race Won’t Decide AstraZeneca's Future

AstraZeneca Plc boss Pascal Soriot recently said he hoped there’d be more than one successful vaccine against Covid-19 given the sheer quantities required. His company’s shares have soared this year largely on hopes for the University of Oxford shot that it’s helping test, manufacture and…

Hot-Desking Is a Good Way to Lose Your Best Staff

Corporate bean counters must be tempted to slash office space as work-from-home advice resumes where Covid cases are surging. But succumbing will mean consequences for recruitment. It’s easy to forget that offices are a retention tool, and will remain so. Everyone knows employers have incentives…

The Rich Still Want to Buy Their Ferraris

The business of making Ferraris is doing embarrassingly well in the pandemic. COVID-19 has affected the production and delivery of luxury cars, but not demand from the wealthy to acquire them, as analysts have noted. The financial impact of the virus on Ferrari NV’s performance is, for now,…

The Problem With Dominant Mark Zuckerberg Types

It irks investors in America, and now it’s irking them in Europe too. The US stock market’s permissive attitude to initial public offerings that give founders super-voting rights is the subject of an international campaign. Rightly so. The US new-issues market is the de facto standard setter for…

Murdoch Gets What He Wants Out of Brexit Britain

The U.K. government has all but approved Rupert Murdoch's bid to take full control of Sky Plc. That's good news for the satellite broadcaster's shareholders. It's also a sign that even the most controversial foreign offers for British companies have a fighting chance of success. U.K. Culture…